Log In
BCIQ
Print this Print this
 

CY-102

  Manage Alerts
Collapse Summary General Information
Company Actus Biotechnologies Inc.
DescriptionTopical formulation of cyclosporine
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPreclinical
Standard IndicationPsoriasis
Indication DetailsTreat psoriasis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today